AMGEN Overview
AMGEN Target Price
Analysts' average 12-month price target for AMGEN is $390.
Get informed when a big investor buys or sells
+ FollowShare Price
$377.35
Average Target Price
$385.75
2.2% upside
2.2% upside24 analysts in the last 4 months
High: $460 | Low: $230
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-09-04 | Wells FargoMohit Bansal | $435 | 15.3% upside |  |
| 2026-08-20 | Piper SandlerDavid Amsellem | $457 | 21.1% upside | |
| 2026-08-19 | Morgan Stanley | $362 |  4.1% downside | |
| 2026-08-19 | Argus Research | $460 | 21.9% upside | |
| 2026-08-18 | Cantor Fitzgerald | $400 | 6% upside | |
| 2026-08-18 | Mizuho Securities | $352 | 6.7% downside | |
| 2026-08-14 | BarclaysEmily Field | $380 | 0.7% upside | |
| 2026-08-10 | GuggenheimVamil Divan | $388 | 2.8% upside | |
| 2026-08-06 | Bernstein | $345 | 8.6% downside | |
| 2026-08-05 | Canaccord GenuityGary Nachman | $384 | 1.8% upside | |
| 2026-08-05 | RBC Capital | $400 | 6% upside | |
| 2026-08-05 | Robert W. BairdBrian Skorney | $230 | 39% downside | |
| 2026-08-05 | ScotiabankLouise Chen | $450 | 19.3% upside | |
| 2026-08-05 | BMO CapitalEvan Seigerman | $450 | 19.3% upside | |
| 2026-08-05 | Oppenheimer | $450 | 19.3% upside | |
| 2026-07-29 | BarclaysEmily Field | $360 | 4.6% downside | |
| 2026-07-13 | UBS | $420 | 11.3% upside | |
| 2026-07-13 | Guggenheim | $343 | 9.1% downside | |
| 2026-07-08 | Morgan Stanley | $333 | 11.8% downside | |
| 2026-07-01 | BMO CapitalEvan David Seigerman | $400 | 6% upside | |
| 2026-06-16 | Mizuho SecuritiesSalim Syed | $303 | 19.7% downside | |
| 2026-06-09 | Morgan Stanley | $340 | 9.9% downside | |
| 2026-06-05 | Goldman Sachs | $389 | 3.1% upside | |
| 2026-05-14 | Piper Sandler | $427 | 13.2% upside | |
| 2026-05-04 | Guggenheim | $340 | 9.9% downside | |
| 2026-05-01 | Morgan Stanley | $332 | 12% downside | |
| 2026-04-20 | Canaccord Genuity | $366 | 3% downside | |
| 2026-04-10 | Morgan StanleyTerence Flynn | $326 | 13.6% downside | |
| 2026-04-09 | Guggenheim | $351 | 7% downside | |
| 2026-04-08 | Truist Financial | $325 | 13.9% downside | |
| 2026-03-10 | JefferiesAkash Tewari | $350 | 7.2% downside | |
| 2026-03-05 | Leerink PartnersDavid Risinger | $355 | 5.9% downside | |
| 2026-02-19 | Barclays | $185 | 51% downside | |
| 2026-02-19 | Wells Fargo | $375 | 0.6% downside | |
| 2026-02-18 | Piper Sandler | $432 | 14.5% upside | |
| 2026-02-11 | Mizuho Securities | $295 | 21.8% downside | |
| 2026-02-04 | RBC Capital | $360 | 4.6% downside | |
| 2026-02-04 | Morgan Stanley | $309 | 18.1% downside | |
| 2026-01-29 | Oppenheimer | $400 | 6% upside | |
| 2026-01-26 | UBS | $390 | 3.4% upside | |
| 2026-01-20 | BernsteinMarket Perform | $335 | 11.2% downside | |
| 2026-01-06 | UBS | $380 | 0.7% upside | |
| 2025-12-12 | Morgan Stanley | $304 | 19.4% downside | |
| 2025-12-10 | HSBC | $425 | 12.6% upside | |
| 2025-12-03 | BMO CapitalEvan Seigerman | $372 | 1.4% downside | |
| 2025-11-25 | Wells Fargo | $400 | 6% upside | |
| 2025-11-24 | Truist Financial | $318 | 15.7% downside | |
| 2025-11-14 | Piper SandlerDavid Amsellem | $381 | 1% upside | |
| 2025-11-06 | Cantor Fitzgerald | $315 | 16.5% downside | |
| 2025-11-05 | Wells Fargo | $300 | 20.5% downside | |